| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2016 | 14159, L.P. | Director, 10% Owner | Buy | 2,586,206 | $29.00 | $74,999,974.00 | +12.9% | |
| Nov 11, 2015 | Iversen Leslie L | - | Sale+OE | 30,000 | $36.01 | $1,080,327.00 | -45.4% | |
| Feb 17, 2015 | Rasmussen Torsten | Director | Sale+OE | 19,847 | $35.05 | $695,544.07 | -70.0% | |
| Feb 17, 2015 | Hacksell Uli | CEO | Sale+OE | 30,000 | $34.30 | $1,028,868.00 | -20.6% | |
| Feb 11, 2015 | Brege Laura62 | Director | Sale+OE | 10,000 | $33.63 | $336,349.00 | -100% | |
| Jan 15, 2015 | Borer Michael T | Director | Sale+OE | 27,973 | $33.02 | $923,766.37 | -100% | |
| Jan 14, 2015 | Hacksell Uli | CEO | Sale+OE | 30,000 | $33.98 | $1,019,430.00 | -20.6% | |
| Jan 13, 2015 | Gray Mary Ann | Director | Sale+OE | 4,250 | $35.00 | $148,750.00 | -100% | |
| Jan 13, 2015 | Rasmussen Torsten | Director | Sale+OE | 11,905 | $35.00 | $416,676.19 | -58.3% |